Literature DB >> 34053631

Gastric Cancer Epidemiology.

Aaron P Thrift1, Theresa H Nguyen2.   

Abstract

In the United States, the incidence of gastric cancer has decreased over the past five decades. However, despite overall decreasing trends in incidence rates of gastric cancer, rates of noncardia gastric cancer among adults aged less than 50 years in the United States are increasing, and most cases of gastric cancer still present with advanced disease and poor resultant survival. Epidemiologic studies have identified the main risk factors for gastric cancer, including increasing age, male sex, non-White race, Helicobacter pylori infection, and smoking. This article summarizes the current epidemiologic evidence with implications for primary and secondary prevention of gastric cancer.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Environment; Genetics; Incidence; Risk factors; Survival

Year:  2021        PMID: 34053631     DOI: 10.1016/j.giec.2021.03.001

Source DB:  PubMed          Journal:  Gastrointest Endosc Clin N Am        ISSN: 1052-5157


  7 in total

1.  Resveratrol inhibits the proliferation, invasion, and migration, and induces the apoptosis of human gastric cancer cells through the MALAT1/miR-383-5p/DDIT4 signaling pathway.

Authors:  Zhuying Yang; Liang Xia
Journal:  J Gastrointest Oncol       Date:  2022-06

2.  Expression of ADAM12 in Gastric Cancer and its Relation to Tumor Cell Behavior and Prognosis.

Authors:  Min-Woo Chung; Young-Lan Park; Sun-Young Park; Young-Eun Joo
Journal:  In Vivo       Date:  2022 Sep-Oct       Impact factor: 2.406

3.  Dynamics of Oxidative Stress in Helicobacter pylori-Positive Patients with Atrophic Body Gastritis and Various Stages of Gastric Cancer.

Authors:  Vladislav Vladimirovich Tsukanov; Olga Valentinovna Smirnova; Edward Vilyamovich Kasparov; Alexander Alexandrovich Sinyakov; Alexander Viktorovich Vasyutin; Julia Leongardovna Tonkikh; Mikhail Alexandrovich Cherepnin
Journal:  Diagnostics (Basel)       Date:  2022-05-11

4.  FSIP1 Is Associated with Poor Prognosis and Can Be Used to Construct a Prognostic Model in Gastric Cancer.

Authors:  Xiuchun Yan; Junzhu Dai; Ying Han; Qi You; Yao Liu
Journal:  Dis Markers       Date:  2022-06-03       Impact factor: 3.464

Review 5.  Claudin18.2 is a novel molecular biomarker for tumor-targeted immunotherapy.

Authors:  Weijie Cao; Haizhou Xing; Yingmei Li; Wenliang Tian; Yongping Song; Zhongxing Jiang; Jifeng Yu
Journal:  Biomark Res       Date:  2022-05-31

6.  Efficacy of Traditional Chinese Medicine Combined with Chemotherapy in the Treatment of Gastric Cancer: A Meta-analysis.

Authors:  Wenxin Zhang; Yijuan Zhao; Hongbo Liu; Chunying Jing
Journal:  Comput Math Methods Med       Date:  2022-08-04       Impact factor: 2.809

Review 7.  Advances in the Aetiology & Endoscopic Detection and Management of Early Gastric Cancer.

Authors:  Darina Kohoutova; Matthew Banks; Jan Bures
Journal:  Cancers (Basel)       Date:  2021-12-13       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.